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Summary
Background In this preliminary study, we investigated 
the sensitivity and specificity of reverse transcriptase 
(RT)-qPCR lymph node (LN) metastases detection, the 
accuracy of intraoperative dye navigation, and the inci-
dence of micrometastasis (MM) detection with this pro-
tocol, compared to other published studies.
Methods A total of 23 patients were enrolled in the 
study. The first stained LN was analyzed using RT-qPCR 
for carcinoembryonic antigen (CEA) and cytokeratin 20 
(CK-20) expression, as markers for MM involvement. 
The Maruyama computer program was used to deter-
mine the most likely first metastatic site. These results 
were compared with the actual staining patterns to 
evaluate whether the first draining LN was extracted. We 
analyzed the correlations between MM and tumor char-
acteristics. The incidence of MM detected with the pres-
ent method was compared to other studies, as markers 
of the accuracy of the present protocol.
Results At 35 threshold cycles, the RT-qPCR had a 
negative predictive value of 100 % and a positive predic-
tive value of 83.3 %. MM were detected in 4 out of 14 
node-negative patients (28.6 %). The extracted sentinel 
LN coincided in 76.9 % of cases with the most probable 
first metastatic LN predicted by the Maruyama program. 
MM were found more frequently in these ‘high-risk’ 
LNs. Significant differences were found in the Lauren’s 
histological type distribution and the age distribution 
among the MM-positive and MM-negative groups.
Conclusion Our preliminary results confirm that RT-
qPCR is an accurate method of MM detection, that the 
dye navigation enables the determination of the first 
draining LN, and that the incidence of MM detection 
with this focused sentinel LN protocol is comparable to 
other studies.
Keywords Gastric cancer · Sentinel lymph node · RT-
qPCR · Maruyama computer program
Introduction
Since its first publication by Morton et al. for melanoma 
patients in 1992 [1, 2], the concept of sentinel lymph node 
(SLN) has been adopted in different fields of oncological 
surgery, and most recently in gastric cancer surgery. SLN 
is defined as the first node that receives the cancer-cell 
drainage from a primary tumor [3, 4], which leads to the 
concept that micrometastases (MM) will develop in the 
SLN first. Although the value of these ‘dormant’ metasta-
ses is still awaiting clinical confirmation, numerous stud-
ies have indicated the prognostic significance of MM [5–7].
The controversy of this subject has been fuelled by the 
varying results in published papers. Many studies have 
indicated that isolated tumor cells in lymph nodes (LNs) 
lack the proliferative capacity to develop full-blown LN 
metastasis [3, 8, 9]. However, a primary reason behind 
the inability to push such a concept into clinical prac-
tice is the method for MM detection. Many studies have 
used routine histological staining with hematoxylin and 
eosin, which lacks sensitivity and specificity [10]. Immu-
nohistochemical staining has been reported to improve 
sensitivity and to be reliable, although this can gener-
ate false negative results by overlooking possible MM 
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that are localized outside the cut slice, or false positive 
results due to antibody cross-reactivity with host stromal 
or inflammatory cells [10, 25]. It has been reported that 
reverse transcriptase polymerase chain reaction (RT)-
PCR is the most sensitive method for the detection of 
MM [11]. The drawbacks of this method are the high cost 
and that it is labor intensive when it is used to evaluate all 
harvested LNs, which limits its usefulness particularly in 
the research setting. Therefore, we searched for an alter-
native method, to retain the benefits of RT-qPCR, while 
still obtaining results in the time-frame necessary to tai-
lor decisions about the extent of the lymphadenectomy. 
While the new RT-qPCR protocols allow the shortening 
of the procedure of LN analysis to 1 h [5, 26], it is still not 
possible to analyze more than one SLN in such a short 
period. The only way to reduce this time with the present 
methods of MM detection is to reduce the number of LNs 
screened. We modified the present gastric cancer SLN 
protocols with the definition of a new hypothesis: that 
tumor cells spread in a predictable fashion, and with cor-
rect LN navigation, there is only the need to analyze one 
‘high-risk’ SLN to obtain the correct regional LN staging.
To evaluate the adequacy of such a concept, one would 
have to assess the recurrence or survival rates, which 
requires a lengthy study period. However, preliminary 
results can be obtained with the use of the Maruyama 
computer program. This program predicts the probability 
of LN metastases of individual gastric cancer patients, by 
comparing their characteristics with those contained in 
its database [12]. Although this program is not designed 
for the prediction of MM, it suggests which nodal stations 
are most likely to be the first metastatic site. Hence, these 
sites might, according to the definition, also have the 
greatest risk of receiving the first isolated tumor cells or 
MM during tumorigenesis.
Thus, the aim of this preliminary study was to deter-
mine the usefulness of this focused SLN protocol, by 
determining whether the LN first marked with Patent 
Blue V dye is most likely to be the first metastatic site. We 
therefore assessed the accuracy of RT-qPCR detection 
of metastatic cells in the LNs, and determined whether 
the intraoperative dye navigation helps in defining the 
most probable first-draining LN. Finally, we compared 
the incidence of MM detected using the present method 
with other studies, where different methods were used 
and more SLNs per patient were analyzed.
Methods
Patients
Twenty-three patients who underwent curative resection 
in the Department for General and Abdominal Surgery at 
the University Clinical Centre of Maribor (Slovenia) were 
included in this study, which started in August 2009. Of 
these 23 patients, 9 were selected as the control group. 
Five patients who were operated on for a pathology other 
than gastric cancer were selected as the negative con-
trol group (right femoral hernia, benign pyloric steno-
sis, Crohn’s disease, hepatocellular carcinoma, sigmoid 
adenoma). The positive control group consisted of four 
patients with LN-positive gastric cancer. During these 
operations, the LNs were extracted from the operative 
field, stored and subsequently analyzed with RT-qPCR in 
a similar fashion to the study group. In the positive con-
trol group, overtly metastatic LNs were extracted for RT-
qPCR analysis. The positive and negative control groups 
were used to determine the sensitivities and specifici-
ties of the RT-qPCR LN metastasis detection at differ-
ent threshold cycles (Ct), and to obtain a Ct for further 
analysis.
All patients in the study group had histologically veri-
fied gastric adenocarcinoma. Preoperative staging was 
performed. Following this work-up, potential Node Zero 
(N0) patients were assessed for inclusion in the present 
study. Only patients who were confirmed to be N0 after 
formal patho-histological analysis of the surgical speci-
mens were included in the present study. All LN speci-
mens were examined using standard hematoxylin-eosin 
staining, and tumor staging was performed according to 
the 7th Edition of the International Union Against Can-
cer TNM classification. Out of the 19 patients included, 
14 were confirmed as N0 after the patho-histological 
analysis. All the patients were presented to a tumor board 
for neoadjuvant chemotherapy or adjuvant chemoradio-
therapy eligibility. Patients with a preoperative clinical 
stage of T3 (subserosal tumor), T4 (tumor spread beyond 
the serosa) or N+ (positive lymph nodes) were consid-
ered for neoadjuvant therapy. Patients with a patho-
logical stage of T3, T4a/b or with positive LNs received 
adjuvant treatment.
All patients gave their written informed consent 
before being included in the present study. This study 
was approved by the National Ethics Committee.
Surgical and sentinel lymph node staining 
techniques and extraction
Surgery started with the exploration of the abdominal 
cavity. The tumor site, clinical stage and resectability 
were defined. Patients with overt nodal metastases or 
tumors spread beyond the serosa were excluded from the 
study. The surgery and the patho-histological evaluation 
were performed according to standards described else-
where for gastric cancer [13].
Before the dissection was performed, Patent Blue 
V Dye (Guerbet Patent Blue V Sodium 2.5 %, Guerbet, 
Roissy, France) was injected in four to five sectors of 
the submucosa around the primary tumor (Fig.  1). The 
lymphatic drainage of the dye was followed for the first 
tumor-draining LN. After 17 ± 6.8  min, the first LN with 
the dye was extracted for RT-qPCR analysis. This LN was 
then immediately placed in RNAlater RNA Stabilization 
Reagent. The submerged specimens were incubated in 
this reagent at 0–4 °C, and analyzed within a month.
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mRNA extraction from sentinel lymph nodes  
and RT-qPCR analysis
The total RNA extracted with RNeasy Mini Plus kits (Qia-
gen, Hilden, Germany) was reverse transcribed using 
High Capacity cDNA Reverse Transcription kits (Applied 
Biosystems). Q-PCR was performed on an ABI PRISM 
7500 Sequence Detection System (Applied Biosystems), 
using TaqMan chemistry in a 96-well format. TaqMan 
Universal PCR Master Mix (Applied Biosystems) and 
the following Gene Expression Assays (Applied Biosys-
tems) were used for CEACAM5 Hs 00237075_m1, KRT20 
Hs00300643_m1, and GAPDH 4333764. Thirty-five cycles 
were selected as the Ct threshold values for CEACAM5 
and CK-20 expression, as determined elsewhere [4, 10].
Statistical analysis
Continuous data are expressed as means ± SD, while cat-
egorical variables are given as percentages. The Shapiro-
Wilk test was used to determine whether the continuous 
data were normally distributed. Comparisons of con-
tinuous variables were carried out with Student’s t-tests 
for parametric data and Mann–Whitney U test for non-
parametric data. Chi-square tests were used for compari-
sons of discrete variables. The sensitivity and specificity 
of the MM determinations were evaluated with a two-
by-two contingency table, where the expression profiles 
of positive and negative controls were compared. The 
Maruyama computer program was used to calculate the 
probabilities of metastases in 16 LN stations. P values 
< 0.05 were defined as the limit of significance. For statis-
tical analysis, PASW version 18 for Windows 7 was used. 
The probability of LN involvement was estimated with 
WinEstimate (version 2.5, München, Germany).
Results
The patient and tumor characteristics for the study group 
are given in Table 1. Out of the 12 patients included, eight 
were N0 patients and had intestinal type of gastric cancer 
(66.7 %). The predominant location of the tumors was the 
lower third (nine cases; 69.2 %) and the lesser curvature 
(five cases; 35.7 %) of the stomach. Early gastric cancer 
was found in nine patients (57.1 %). Five patients had 
locally advanced gastric cancer. The cancer was mostly 
poorly differentiated tubular adenocarcinoma (five cases; 
41.7 %). Only two patients from the study group (14.3 %) 
received chemotherapy. Both of these two patients were 
under-staged with preoperative diagnostics and had not 
received neoadjuvant treatment. After the formal patho-
histological analysis, one of these two patients was found 
to have a T4a stage tumor, while the other had a T3 stage 
tumor. In each case, these patients received adjuvant 
treatment with capecitabine plus radiotherapy.
To evaluate the sensitivity, specificity, and the positive 
and negative predictive values of RT-qPCR for carcinoem-
bryonic antigen (CEA) and cytokeratin 20 (CK-20) detec-
tion, a two-by-two contingency table was constructed 
(Table  2). The sensitivity of this method at Ct 35 cycles 
was 75 %, with a specificity of 100 %. The negative predic-
tive value was 100 %, and the positive predictive value 
was 83.3 %. These results obtained with Ct 35 cycles were 
comparable to other studies, and therefore the further RT-
qPCR analysis was carried out with this threshold value.
The next step was the evaluation of the study group 
(Table 3). Of the 14 histologically confirmed N0 patients, 
4 (28.6 %) showed MM, while no CEA or CK-20 expression 
was detected in the remaining 10 patients, who were thus 
MM negative. There were no differences in gender dis-
tribution, preoperative tumor marker values, location of 
tumor, early gastric cancer type, Bormann type, tumor size, 
number of resected LNs, vascular, lymphangial or perineu-
ral invasion, extranodal infiltration, histological grade, and 
T-stage distribution. The patients in the MM-positive group 
were significantly older than the patients with no MM 
(55 ± 8.7 vs. 69 ± 8.9 years; P = 0.019). A significant differ-
ence was noted in the Lauren histological type distribution 
(P = 0.037). In the MM-negative group, the most prevalent 
histological type was intestinal, in 88.9 % of cases (eight 
patients). In the MM-positive group, most of the patients 
had the diffuse type of gastric cancer (66.7 %; two patients). 
No patient with MM had an intestinal type of cancer.
All of the patients were analyzed retrospectively with 
the WinEstimate computer program, to estimate the like-
lihood of LN metastases. With this program, the most 
Fig. 1 SNL mapping with Patent Blue V dye. a Submucosal infiltration with the dye. b Identification of lymphangial vessels and 
drainage to the first LN. c Extraction of the first-draining LN
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Table 1. Patient and tumor characteristics










Mid third 4 (30.8 %)
Lower third 9 (69.2 %)
Tumor site
Lesser curvature 5 (35.7 %)
Greater curvature 3 (21.4 %)
Anterior wall 1 (7.1 %)
Posterior wall 4 (28.6 %)
Circular involvement 1 (7.1 %)














Tubular well differentiated 3 (25 %)
Tubular moderate differentiated 3 (25 %)
Tubular poor differentiated 5 (41.7 %)
Signet ring-cell 1 (8.3 %)
CEA (ng/ml) 1.4 ± 1.07
AFP (ng/ml) 3.5 ± 1.92 
CA 19-9 (ng/ml) 10.33 ± 13.27 
Tumor size (mm) 34.1 ± 22.11 
Extraction time (min) 17.8 ± 6.9 
Total number of resected lymph nodes 12.4 ± 7.9
Table 2. Two-by-two contingency table
Control Total
Negative Positive
RT-qPCR negative 4 11 15
RT-qPCR positive 0  7  7
Total 4 18 22
RT-qPCR expression (n, %) P
Positive Negative
Gender NS
 Male 2 (50 %) 8 (80 %)
 Female 2 (50 %) 2 (20 %)
Age (years) 55 ± 8.7 69 ± 8.9 0.019
Lauren type 0.037
 Intestinal 0 (0 %) 8 (88.9 %)
 Diffuse 2 (66.7 %) 0 (0 %)
 Mixed 1 (33.3 %) 1 (11.1 %)
Tumor third NS
 Mid third 2 (50 %) 2 (22.2 %)
 Lower third 2 (50 %) 7 (77.8 %)
Tumor site NS
 Lesser 2 (50 %) 3 (30 %)
 Greater 1 (25 %) 2 (20 %)
 Anterior 0 (0 %) 1 (10 %)
 Posterior 1 (25 %) 3 (30 %)
 Circular 0 (0 %) 1 (10 %)
EGC type NS
 I 1 (50 %) 1 (14.3 %)
 IIb 0 (0 %) 2 (28.6 %)
 IIc 1 (50 %) 2 (28.6 %)
 III 0 (0 %) 2 (28.6 %)
Bormann type NS
 III 1 (50 %) 2 (66.7 %)
 IV 1 (50 %) 1 (33.3 %)
T stage NS
 T1a 1 (25 %) 4 (40 %)
 T1b 1 (25 %) 2 (20 %)
 T2 1 (25 %) 3 (30 %)
 T3 1 (25 %) 1 (10 %)
Differentiation NS
 Tubular well 0 (0 %) 3 (33.3 %)
 Tubular moderate 1 (33.3 %) 2 (22.2 %)
 Tubular poor 2 (66.7 %) 3 (33.3.%)
 Signet ring-cell 0 (0 %) 1 (11.1 %)
Lymphangial invasion NS
 Negative 4 (100 %) 9 (90 %)
 Positive 0 (0 %) 1 (10 %)
Vascular invasion NS
 Negative 4 (100 %) 10 (100 %)
 Positive 0 (0 %) 0 (0 %)
Perineural invasion NS
 Negative 3 (75 %) 8 (80 %)
 Positive 1 (25 %) 2 (20 %)
Extranodal infiltration NS
 Negative 4 (100 %) 10 (100 %)
 Positive 0 (0 %) 0 (0 %)
Table 3. Comparison of MM-positive and MM-negative 
groups
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likely metastatic site was determined and compared with 
the LN stations determined to be the first-draining site of 
the tumor with intraoperative Patent Blue V staining. The 
extracted LN coincided in 76.9 % with the WinEstimate-
predicted LN stations in the N0 patients. Although insig-
nificant due to the low case numbers, MM were more 
frequently found in correctly predicted nodes (with a 3:1 
ratio in favor of the correctly predicted LN).
Discussion
With a more liberal use of gastroscopy in symptomatic 
patients, there has been a slow but significant rise in the 
detection of early gastric cancer in Slovenia [14, 15]. In 
these early favorable stages, limited and less aggressive 
treatment methods are being explored; however, these 
must rely on more accurate tumor staging. Unfortunately, 
till date, there is no preoperative diagnostic tool that can 
reliably detect nodal metastases in gastric cancer patients 
[28]. Usually, surgeons rely on the scarce preoperative 
staging and the intraoperative clinical assessment to 
determine the best type of resection for early and node-
negative gastric cancer. As the first metastatic deposits in 
early gastric cancer are usually in the form of MM, such 
clinical staging during the operation is at best question-
able. If a restrictive policy towards extended lymphad-
enectomy is taken, as many as 20 % of early gastric cancer 
patients will have an insufficiently defined operation [1]. 
Therefore, other methods of selection for more extensive 
operations are being explored.
The SLN concept that has revolutionized melanoma 
and breast cancer treatment might bring new concepts 
to gastric cancer surgery. However, in contrast to breast 
cancer or melanoma, where metastatic deposits follow a 
predictable path to the LNs and are large enough to be 
detected in frozen sections, so that the relevant results 
can be obtained in 30  min [3]. LN metastases in early 
gastric cancer are usually packed into small groups of 
cells on the periphery of the lymph node [5]. This makes 
it harder to detect them with routine histological meth-
ods. To increase the sensitivity and specificity for MM 
detection, extensive sectioning is at present necessary 
to obtain representative sensitivities and specificities. 
Many studies even resort to immunohistochemical and 
molecular analysis of large numbers of lymph nodes [10, 
11, 25]. While RT-qPCR is said to be the most sensitive 
and specific method, it is still notoriously elaborate and 
expensive; and it takes too long to provide an efficient 
selection tool for the surgeon. We therefore tried to mod-
ify the protocols used at present to detect MM, to retain 
some of the advantages of this molecular tool while 
reducing the time to obtain relevant results. The only way 
to achieve such an endeavor was to reduce the number of 
LNs examined, by examining only the first-draining SLN.
To determine the validity of the proposed focused SNL 
protocol long-term survival analysis is necessary. Patients 
with early gastric cancer have excellent survival [1], so the 
first impact of MM is expected to be on disease-free sur-
vival of the patients. When present in early gastric cancer, 
the first signs of local failure develop after 5 years [20]. As 
the first relevant results can only be expected after such 
a long observational period, we designed a preliminary 
study to determine whether MM can be reliably detected 
by examination of only one ‘high-risk’ SLN. This is, in our 
opinion, a critical prerequisite before embarking on a 
larger trial for the clinical application of this concept. We 
therefore investigated the sensitivity of RT-qPCR detec-
tion of LN metastases, the accuracy of the intraoperative 
dye navigation, and the incidence of MM detection using 
this protocol, as compared to other published studies.
The double marker RT-qPCR assays used in the pres-
ent study proved to be a sensitive and specific tool for the 
detection of MM in LNs. At Ct 35 cycles, we achieved a 
negative predictive value of 100 % and a positive predic-
tive value of 83.3 % in the control groups. These values 
confirm the possibility for the confident use of RT-qPCR 
for further investigations. Similar results were obtained 
in other studies, where RT-qPCR was determined to have 
superior sensitivities and specificities to standard hema-
toxylin and eosin analysis and immunohistochemical 
staining [4, 5, 10, 16].
Even if we achieve impressive accuracies with these 
RT-qPCR double-marker assays, the method in itself does 
not allow the time interval of the analysis to be shortened 
when all of the LNs from a stained LN basin are screened 
for MM. In similar studies, up to 15 LNs were examined 
with a mean of 2–4 [3–10, 16–19]. The present study is thus 
in sharp contrast here, with only one examined SLN. We 
based our protocol on extensive lymphograpy studies, 
which have shown that at least for early gastric cancer, 
MM occur according to a predictable path [16, 27]. Indeed, 
even in studies where extensive immunohistochemical 
staining analysis of LNs of the pregastric compartment 
were performed, MM were never found only outside the 
stained SLNs [19]. It can be assumed that in spite of a more 
complex lymphatic drainage of the stomach wall, MM are 
usually first formed in the SLNs. It would thus theoretically 
suffice to examine only the first-draining node, under the 
condition that the extracted LN is indeed the true SLN.
To determine whether dye navigation can reli-
ably define the most-probable first-draining site, the 
Maruyama computer program was used. The extracted 
LNs in the present study coincided in 76.9 % of cases 
 
RT-qPCR expression (n, %) P
Positive Negative
CEA (ng/ml) 1 ± 0 1.57 ± 1.3 NS
AFP (ng/ml) 3 ± 1.7 3.8 ± 2.2 NS
CA 19-9 (ng/ml) 22 ± 17.8 4 ± 5 NS
Tumor size (mm) 30 ± 12 35 ± 25.5 NS
Number of extracted lymph 
nodes
13 ± 9.8 12 ± 7.5 NS
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with the nodal station predicted to be the most frequent 
metastatic site by the Maruyama computer program. 
We also determined that although not reaching signifi-
cance in the present study, MM were more frequent in 
the nodes predicted by the Maruyama program to be the 
most-probable first metastatic site. Not only does this 
confirm that dye navigation leads to the correct defini-
tion of the first-draining node, but it also emphasizes 
the importance of the correct LN navigation. Meticu-
lous intraoperative dye injections as close as possible to 
the tumor are of the utmost importance for the present 
method. Perhaps additional methods, such as the pre-
operative labeling of the tumor site with dyes containing 
particles of a specific size that will remain lodged only in 
the first-draining node [5], can be used to increase the 
yield of ‘true’ SLNs. The evolution of such staining pat-
terns remains a subject of future studies.
Even if we extract the first-draining node, it still does 
not confirm that MM can be reliably detected. The pres-
ent method can still suffer from insufficient sensitivities 
of RT-qPCR for MM detection, aberrant marker expres-
sion, and inadequate staining patterns. An indication 
for appropriate MM detection is the MM frequency. 
If MM are missed because of the analysis of the wrong 
SLN, a much lower incidence of MM would be expected 
than in comparable studies, where more LNs per patient 
are examined. In our cohort, 4 out of 12 node-negative 
patients (28.6 %) were MM positive. In other studies, the 
presence of MM ranged from 10 to 30 % [3–10, 16–19].
Our results also indicate that MM are more common 
in older patients and in the diffuse type of gastric can-
cer. The higher prevalence of MM in the older population 
might reflect their lower immunocompetence. Sansoni 
et al. reported dysfunction of the natural killer cells in 
older patients, which can fail to clear isolated tumor cells 
lodged in LNs, resulting in higher incidence of MM [3, 20, 
21]. Higher incidence of MM in the diffuse type of gas-
tric cancer has also been reported in other studies [22]. 
These findings can be extremely important in the work-
up of preoperative patients, and they need to be further 
explored in future studies.
Taken together, our preliminary results confirm that 
RT-qPCR is an accurate method of MM detection, that 
dye navigation enables the first-draining node to be 
found, and analysis of the ‘high-risk’ SLN can detect MM 
with the same efficiency as the more elaborate LN screen-
ing protocols. Considering these findings, we are deter-
mined to refine our method so as to more fully merge the 
advantages of the superior sensitivities and specificities 
of RT-qPCR with the cost benefits and the speed of this 
focused SLN concept.
Conclusions
Although these data indicate that single SLN screening 
is an accurate method of SLN evaluation, these results 
remain preliminary. Only recurrence and long-term 
survival analysis on larger series of patients will be able 
to reveal the full validity of the present method. If this 
method is further proven to be effective, the results can be 
used intraoperatively. With the development of methods 
such as transcription-reverse transcription concerted 
reaction, one-step nucleic-acid amplification assay, and 
fully automated multiplex quantitative RT-PCR, which 
generate results that are equal to standard RT-qPCR in 
no more than 20 min to 1 h [5, 26], single SLN analysis 
might be the first step along the road toward intraopera-
tive decision making, which would thus usher in the age 
of tailored, limited surgery for gastric cancer.
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